Biden administration paid hospital Covid-19 funds to drugmakers; hospitals deny transplants for the unvaccinated

The administration took nearly $7 billion from a fund meant to help hospitals and clinics and used it to buy Covid vaccines and therapeutics. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

The Biden administration used billions in hospital Covid-19 funds to pay drugmakers By Rachel Cohrs Alex Wong/Getty Images The administration took nearly $7 billion from a fund meant to help hospitals and clinics and used it to buy Covid vaccines and therapeutics. Read More Hospitals are denying transplants for patients who aren't vaccinated against Covid, with backing from ethicists By Andrew Joseph Eraldo Peres/AP Hospitals are denying transplants for patients who aren't vaccinated against Covid, with backing from ethicists. Read More STAT+: Akili, maker of prescription video game to treat ADHD, to go public via SPAC By Mario Aguilar Akili Akili, which makes a video game that to treat ADHD in adolescents, announced plans Wednesday to go public in a SPAC merger. Read More Sponsor content by STAT Events STAT Event: How biomarkers are changing cancer care The way doctors treat cancer is evolving. On Feb. 2, STAT looks into this by examining how advances in technology are changing the way biomarkers are used. Register here to join the conversation. Why Hong Kong may become a living laboratory in search for Covid-19 answers By Helen Branswell There are still questions about Omicron as well as a new subvariant, known as BA.2. Hong Kong may help answer them. Read More STAT+: Future of Gilead blood cancer drug is clouded after studies are stopped due to safety issue By Adam Feuerstein Yichuan Cao/Sipa USA With the future of magrolimab now in doubt, pressure builds on Gilead to maximize the potential of its other cancer-focused acquisitions. Read More Early research suggests cancer drug could help flush HIV from its hiding spots By Angus Chen NIAID/NIH New, early-stage research suggests the cancer drug Keytruda could also help flush latent HIV from the hidden reservoirs where it lurks. Read More Opinion: Listen: Burnout at the bedside is causing a crisis in nursing By Patrick Skerrett Nurse-researcher Jane Muir explores some of the reasons nurses are giving up staff jobs and offers ways to retain these essential workers. Read More Opinion: How Black hair racism affects mental health care By Amanda Joy Calhoun Adobe Electroconvulsive therapy technology was not designed with Black hair in mind. Why should Black people have to adapt? Read More STAT+: A former FDA official on making the jump to health tech startups By Mario Aguilar FDA Anand Shah, a former FDA official, is joining the board of Big Health, a leading player in the burgeoning digital therapeutics sector. Read More Wednesday, January 26, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser